October 2023
Recent medical device news highlights related to Class III implantable medical devices in the areas of cardiac rhythm management and diabetes treatment. Always ensure to follow up on the provided links for detailed information.
I found MITs implantable device with pancreatic islet cells and an oxygen factory fascinating and scary. I would have so many concerns if my doctor told me they were implanting a device in me that would take water vapor in my body and split it into oxygen and hydrogen.
Cardiac Rhythm Management
- Avertix Data at TCT 2023 (10/24/2023) – The Guardian System, the first and only FDA-approved implantable heart device, shows a 150% increase in medication adjustments of antiarrhythmics for high-risk heart attack survivors. Read more
- Philips at TCT 2023 (10/19/2023) – Philips showcases its latest medical innovations and solutions for patients with cardiovascular disease. Read more
- Abbott’s Assert-IQ™ (05/18/2023) – Abbott receives FDA clearance for its Assert-IQ™ Insertable Cardiac Monitor to help doctors monitor people’s heart rhythms long-term. Read more
- Medtronic Recall (07/25/2023) – Medtronic recalls nearly 350,000 defibrillators due to the risk of reduced shock. The implantable devices may fail to correct a life-threatening arrhythmia, leading to cardiac arrest. Read more
Diabetes Treatment:
- MIT’s Implantable Device (10/07/2023) – MIT announces the creation of an implantable device that produces insulin, offering a promising approach to treating Type 1 diabetes. Read more
- GE HealthCare & Novo Nordisk Partnership (10/20/2023) – The partnership aims to treat chronic diseases like type 2 diabetes and obesity using ultrasound. Read more
- Vivani Medical (10/18/2023) – The company is developing an implant for the treatment of type 2 diabetes and obesity. Read more
- Medtronic’s CGM-Insulin Pen Combo (10/18/2023) – Medtronic introduces a combo that simplifies diabetes management. Read more
Enjoy reading!
C. Austin Insight 